["{\"step_by_step_thinking\": \"There is no relevant information about tocilizumab or csDMARD (certified small molecule disease-modifying anti-rheumatic drug) in the provided documents. The documents primarily discuss retinal detachment, vitreous surgery, retrograde cardioplegia, coronary sinus cannulation technique, a graphic method for plasminogen estimation, and complications after myelography with Dimer-X. Therefore, it is not possible to determine whether tocilizumab is a csDMARD based on the provided information.\", \"answer_choice\": B}"]